Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Constant tremors, difficulty standing and walking, mental disorders, and sleep disturbances are all symptoms of Parkinson's ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

A paper on the methods being used in the company’s clinical study, named ADAPT-PD, was published this week in the Nature ...